A Study to Evaluate the Effect of add-on Pioglitazone or Glimepiride in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by Alogliptin and Metformin Therapy

Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: SYR-322-4833;   Drug: Alogliptin;   Drug: Metformin;   Drug: Glimepiride Sponsor:   Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials